Outpatient PPS

Injection, cabotegravir and rilpivirine, 2mg/3mg

Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Injection, casimersen, 10 mg

Injection, lumasiran, 0.5 mg

Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Injection, immune globulin (asceniv), 500 mg

Injection, viltolarsen, 10 mg

Injection, tafasitamab-cxix, 2 mg

Injection, belantamab mafodontin-blmf, 0.5 mg

Copper cu-64, dotatate, diagnostic, 1 millicurie